Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.
In February 2024, the U.S. Food and Drug Administration approved the injectable biologic medication Xolair® (omalizumab) to treat food allergy in certain adults and children 1 year or older to reduce ...